Filter by:

Reset Filter
  • Antitrust and Competition
Showing 49 - 60 of 353
Article

Innovation in Merger Control

This article discusses the considerations for forward looking economic analysis of dynamic innovation and R&D effects in mergers.

Article

Cross-Market Implications in FTC's Anesthesia Complaint

The authors discuss how precedents from this case could potentially provide a framework under which the FTC will challenge mergers.

Event

Resale Price Maintenance & the Digital Age

Nathaniel Hipsman will moderate a panel of practitioners, economists, and government enforcement officials at this American Bar Association event.

Event

The Global Antitrust Economics Conference

Rainer Schwabe and Anand Krishnamurthy will join competition experts to discuss the role of financial services and life sciences in antitrust.

Event

FTC v. US Anesthesia Partners: Serial Acquisitions and Private Equity in Focus

Laurien Gilbert will moderate a panel of attorneys to discuss the role of private equity firms in healthcare.

Event

GCR Live: Women in Antitrust 2023

Avigail Kifer will join a panel titled, “Novel Theories of How Mergers Harm Competition” at this annual conference in Washington, DC.

Event

Global Class Actions Symposium 2023

Vikram Kumar will chair a panel about calculating damages in large class actions at this London conference.

Press Release

John Asker Appointed to New Australian Competition Taskforce Advisory Panel

Professor Asker joins an expert panel appointed to advise the Australian government on potential changes to the country's competition policy settings.

Article

Bid Rigging and Umbrella Damages

This article analyzes the role of umbrella damages when conducting damage assessment in bid-rigging cases.

Event

IBA 2023: International Bar Association Annual Conference

Joanna Tsai will speak on a panel titled “The Boundaries of Unilateral Conduct” at this annual conference in Paris.

Case

Value Drug Company v. Takeda Pharmaceuticals U.S.A. Inc. et al.

Laurence Baker testified during a rare antitrust trial centering on the allegation that a brand manufacturer conspired with three generics to allocate the market for gout medication colchicine.

Press Release

Dr. Joanna Tsai Joins Cornerstone Research as Vice President

Prominent merger economics expert brings global experience in high-stakes mergers, acquisitions, joint ventures, and other antitrust matters.

How can we help you?

If you are looking for a publication not on our website, contact us.